Muhammad Imran, Tariq Javed, Asma Jabeen, Gul Mehnaz, Kalim Ullah, Nusrat Shaheen, Sofia Khalid, Muhammad Imran Amirzada, Muhammad Arafat Yameen, SM Farid Hasan, Sajid Hussain Shah, Khalid Rauf, Gary Schenk, RossMcGeary, Luc Pieters, Muhammad Latif, Yasser MSA Al-Kahraman, Muhammad Hassham Hassan Bin Asad
Aim of this study was to synthesize new inhibitors on the basis of active site of aspartic protease enzyme and to evaluate their intended biological activity.
Amide ligands
aspartic protease
molecular docking
anti-leishmanial activity.